FPT Launches MediSight Framework to Accelerate AI-Driven Healthcare and Life Sciences Innovation

HANOI, Vietnam--(BUSINESS WIRE)--Jul 15, 2026--

Global IT corporation FPT announced the launch of MediSight, an AI-powered framework designed to help healthcare providers, medical device manufacturers, and pharmaceutical organizations accelerate digital transformation, strengthen regulatory compliance, and unlock actionable insights from healthcare data. The framework combines autonomous AI digital workers, healthcare-specific applications, and AI-augmented engineering capabilities to streamline clinical, operational, and regulatory workflows while enabling faster, data-driven decision-making across the healthcare value chain.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715661578/en/

Built on FPT's FleziPT AI-first ecosystem and guided by CASAN, FPT's framework for progressing from AI experimentation to AI-native operations, MediSight enables healthcare and life sciences organizations to scale AI adoption across care delivery, business operations, and compliance functions. Combining AI agents, industry-specific accelerators, and AI-powered engineering capabilities, the solution converts fragmented healthcare information into structured intelligence, supporting faster innovation, stronger governance, and informed decision-making.

The framework is structured around three core layers. The Healthcare Insight Platform (HIP) provides a cloud-native, interoperable data foundation supporting standards such as HL7 v2, CDA, FHIR, and DICOM, with built-in capabilities for data mapping, de-identification, and clinical terminology standardization. MediSight Crew comprises autonomous AI agents, digital workers, and healthcare-focused assistants that support administrative, clinical, and compliance activities. MediSight Verse offers a growing portfolio of applications spanning clinic management, claims administration, virtual care, patient engagement, clinical trials, medical imaging, documentation, and healthcare analytics.

Designed for healthcare-grade security, MediSight supports industry requirements including HIPAA, HITRUST r2, and ISO 27001. The framework can be deployed across major cloud environments and integrated with leading healthcare systems, enabling greater data traceability, streamlined compliance processes, accelerated product development, and more efficient patient care.

Chu Canh Chieu, FPT Software Vice President and Head of Healthcare and Life Sciences, FPT Corporation, stated: “The next phase of healthcare innovation demands systems that don't just store data, but actively reason through it. MediSight helps healthcare organizations reduce manual effort, improve decision-making speed, and scale digital health solutions more efficiently. By fusing autonomous AI agents with specialized clinical applications, we are helping digital health and pharma enterprises eliminate manual friction, reduce time-to-market for medical software, and elevate patient outcomes without compromising on strict regulatory standards."

The launch of MediSight further strengthens FPT's healthcare and life sciences portfolio. With nearly two decades of experience serving healthcare providers, pharmaceutical companies, and medical device manufacturers worldwide, FPT supports organizations in advancing operational efficiency and patient-centric care. FPT has attained key healthcare certifications and standards, including HITRUST r2, HIPAA-compliant, ISO 9001, ISO 13485, IEC 62304, HL7, and DICOM, reinforcing its capability to deliver solutions for highly regulated healthcare environments.

About FPT

FPT Corporation (FPT) is a globally leading Vietnam-headquartered technology and IT services provider, with operations spanning more than 30 countries and territories. Over more than three decades, FPT has consistently delivered impactful solutions to millions of individuals and tens of thousands of organizations worldwide. With a strong focus on mastering strategic technologies, FPT continues to drive innovation across industries. As an AI-first company, FPT is committed to elevating Vietnam’s position on the global tech map and delivering world-class AI-enabled solutions for global enterprises. In 2025, FPT reported a total revenue of USD 2.66 billion and a workforce of over 54,000 employees across its core businesses.

For more information, please visit https://fptsoftware.com/.

FPT Launches MediSight Framework to Accelerate AI-Driven Healthcare and Life Sciences Innovation

NEW YORK (AP) — Zheng Qinwen made a daring escape from a 5-0 deficit for the second straight match, with this comeback sending her back into the U.S. Open quarterfinals.

The Olympic gold medalist from China beat No. 8 seed Iga Swiatek 7-5, 6-3 on Monday to become the first qualifier to reach the final eight in Flushing Meadows since Emma Raducanu won the title in 2021.

Two days after she was down 5-0 in the third set before winning the final seven games to stun No. 22 Madison Keys 1-6, 7-6 (3), 7-5, Zheng quickly dropped the first five games against Swiatek, the 2022 U.S. Open champion.

“I guess to come back 0-5 yesterday is not lucky, that’s all I can say,” Zheng said.

Swiatek couldn't convert two set points serving at 5-1 and Zheng fought off another when Swiatek served with a 5-3 lead. She said she was so focused on each point that she even forgot the score.

Zheng was a U.S. Open quarterfinalist in 2023 and 2024 but after elbow surgery had to go through qualifying this year to reach the main draw. Raducanu's title five years ago made her the first qualifier to win a Grand Slam title in the Open era, which dates to 1968.

Swiatek came in with a 7-1 record against Zheng, with the only loss two years ago in the Olympic semifinals in Paris. Zheng came back from a 4-0 deficit in the second set that day to stop Swiatek’s 25-match winning streak at Roland Garros, where she has won four French Open titles.

Zheng will play either two-time champion Naomi Osaka or No. 2 Elena Rybakina in the quarterfinals.

French Open champion Mirra Andreeva came back to beat No. 24 Anastasia Potapova 5-7, 6-4, 6-3 and the No. 5 seed will face either No. 4 Coco Gauff or No. 14 Iva Jovic. The two Americans meet Monday night in the opening match of the night session.

See AP’s full tennis coverage here

Iga Swiatek, of Poland, receives a massage during a medical timeout durnig a match against Qinwen Zheng, of China, during the fourth round of the U.S. Open tennis championships, Monday, Sept. 7, 2026, in New York. (AP Photo/Seth Wenig)

Iga Swiatek, of Poland, returns the ball to Qinwen Zheng, of China, during the fourth round of the U.S. Open tennis championships, Monday, Sept. 7, 2026, in New York. (AP Photo/Seth Wenig)

Iga Swiatek, of Poland, reacts during a match against Qinwen Zheng, of China, during the fourth round of the U.S. Open tennis championships, Monday, Sept. 7, 2026, in New York. (AP Photo/Seth Wenig)

Qinwen Zheng, of China, reacts during a match against Iga Swiatek, of Poland, during the fourth round of the U.S. Open tennis championships, Monday, Sept. 7, 2026, in New York. (AP Photo/Seth Wenig)